The association between sodium glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population‐based cohort study

Documenti analoghi

• Initiation of sodium‐glucose cotransporter‐2 inhibitors and the risk of infection‐related hospitalisations: A population‐based cohort study
  di: Maria J. Alfonso Arvez, et al.
  Pubblicazione: (2025)
• Comparison between sodium‐glucose cotransporter 2 inhibitors and dipeptidyl peptidase 4 inhibitors on the risk of incident cancer in patients with diabetes mellitus: A real‐world evidence study
  di: Hui‐Lin Sung, et al.
  Pubblicazione: (2024)
• Superior benefits of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease: A cohort study
  di: Hsiao‐Ling Chen, et al.
  Pubblicazione: (2024)
• Risk of insulin initiation with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes mellitus: A real‐world claims database study in Japan
  di: Ryo Suzuki, et al.
  Pubblicazione: (2025)
• Association between the body mass index and risk of cardiovascular events in sodium‐glucose cotransporter 2 inhibitor users compared with dipeptidyl‐peptidase 4 inhibitor users: A nationwide cohort study in Korea
  di: Hwa Yeon Ko, et al.
  Pubblicazione: (2025)